Background
Lee joined Hankook Yakult, now hy and Curexo's main shareholder, in 1991. He became vice president of Curexo in 2011 and chief executive in 2012.1,2
Leading Curexo
Under Lee, Curexo installed its 100th CUVIS-joint and won FDA 510(k) clearance for CUVIS-spine.2,3
Revenue rose 34 percent to 74.5 billion won in 2025, and medical robot sales grew 88 percent as the company returned to an operating profit.4,5
Links
Sources
- Curexo, About us, accessed November 13, 2026
- Curexo, History, accessed November 13, 2026
- Curexo, English homepage, accessed November 13, 2026
- Curexo, 2025 business report filed with the Korea Exchange (March 17, 2026), accessed November 13, 2026
- Medicopharma, Curexo returns to consolidated operating profit on medical robots and implants, accessed November 13, 2026




